Literature DB >> 15723094

Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Kylie J Mansfield1, Lu Liu, Frederick J Mitchelson, Kate H Moore, Richard J Millard, Elizabeth Burcher.   

Abstract

1. We investigated muscarinic receptors in the detrusor and mucosa of the human bladder body. Radioligand-binding studies with [(3)H]QNB were conducted using specimens collected from patients (36-77 years) with normal bladder function, undergoing surgery. For RT-PCR, biopsies of normal bladder were obtained from patients (30-88 years) undergoing check cystoscopy. 2. Binding of [(3)H]QNB in detrusor (n=20) was of high affinity (K(D) 77.1 (55.2-99.0) pM) and capacity (B(max) 181+/-7 fmol mg protein(-1)). Similar values were obtained in mucosa (n=6) (K(D) 100.5 (41.2-159.9) pM; B(max) 145+/-9 fmol mg protein(-1)). 3. Competition-binding experiments in detrusor membranes with muscarinic receptor antagonists including trospium, darifenacin, 4-DAMP, methoctramine, AQ-RA 741, AF-DX 116 and pirenzepine indicated a receptor population of 71% M(2), 22% M(3) and 7% M(1). In the mucosa, 75% of sites were M(2) receptors, with 25% M(3)/M(5). 4. Using RT-PCR, expression of M(1), M(2), M(3) and M(5) mRNA was demonstrated in both detrusor and mucosa. 5. The presence of a high density of mainly M(2) muscarinic receptors in the mucosa appears to be a novel finding and raises the question of their physiological significance and the source of their endogenous ligand. 6. There was a negative correlation of receptor number (B(max)) with age in detrusor muscle from male patients (P=0.02). Quantitative competitive RT-PCR demonstrated a selective age-related decrease in mRNA for muscarinic M(3) but not M(2) receptors, in both male (P<0.0001) and female (P=0.019) detrusor. These findings correspond with reports of decreased detrusor contractility with ageing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723094      PMCID: PMC1576093          DOI: 10.1038/sj.bjp.0706147

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.

Authors:  R Chess-Williams
Journal:  Auton Autacoid Pharmacol       Date:  2002-06

2.  M(3) muscarinic receptors mediate contraction of human urinary bladder.

Authors:  Charlotte Fetscher; Marina Fleichman; Martina Schmidt; Susanne Krege; Martin C Michel
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

3.  Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable.

Authors:  Minoru Matsui; Daisuke Motomura; Toru Fujikawa; Jian Jiang; Shin-ichi Takahashi; Toshiya Manabe; Makoto M Taketo
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

4.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.

Authors:  I Milsom; P Abrams; L Cardozo; R G Roberts; J Thüroff; A J Wein
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

5.  Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder.

Authors:  Sandra Sigala; Giuseppe Mirabella; Angelo Peroni; Giuseppe Pezzotti; Claudio Simeone; PierFranco Spano; Sergio Cosciani Cunico
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

6.  Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder.

Authors:  M K Pagala; L Tetsoti; D Nagpal; G J Wise
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

7.  Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.

Authors:  L A Birder; Y Nakamura; S Kiss; M L Nealen; S Barrick; A J Kanai; E Wang; G Ruiz; W C De Groat; G Apodaca; S Watkins; M J Caterina
Journal:  Nat Neurosci       Date:  2002-09       Impact factor: 24.884

8.  The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro.

Authors:  R Chess-Williams; C R Chapple; T Yamanishi; K Yasuda; D J Sellers
Journal:  J Auton Pharmacol       Date:  2001 Oct-Dec

9.  Does gender or age affect the efficacy and safety of tolterodine?

Authors:  Martin C Michel; Tim Schneider; Susanne Krege; Mark Goepel
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

Review 10.  Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

Authors:  K-E Andersson; M Yoshida
Journal:  Eur Urol       Date:  2003-01       Impact factor: 20.096

View more
  51 in total

1.  [Characteristic changes in the pattern of distribution of muscarinic receptors in the exstrophic bladder wall].

Authors:  W H Rösch; M Hagemann; I Hanisch; W L Neuhuber
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

Review 2.  Urothelial effects of oral agents for overactive bladder.

Authors:  Karl-Erik Andersson; Claudius Fullhase; Roberto Soler
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

3.  In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats.

Authors:  Takanobu Yamazaki; Yukiko Muraki; Tsuyoshi Anraku
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-08-05       Impact factor: 3.000

Review 4.  The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors:  Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal:  Ther Adv Urol       Date:  2016-11-04

5.  M3-subtype muscarinic receptor activation stimulates intracellular calcium oscillations and aldosterone production in human adrenocortical HAC15 cells.

Authors:  Latha M Malaiyandi; Harsh Sharthiya; Nuntida Surachaicharn; Yara Shams; Mohammad Arshad; Chad Schupbach; Phillip G Kopf; Kirk E Dineley
Journal:  Mol Cell Endocrinol       Date:  2018-06-28       Impact factor: 4.102

Review 6.  Non-neurogenic Chronic Urinary Retention: What Are We Treating?

Authors:  John T Stoffel
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

Review 7.  The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Authors:  Karl-Erik Andersson; Nurul Choudhury; Jean-Nicolas Cornu; Moses Huang; Cees Korstanje; Emad Siddiqui; Philip Van Kerrebroeck
Journal:  Ther Adv Urol       Date:  2018-07-06

Review 8.  Perspectives on overactive bladder in the elderly population.

Authors:  Masaki Yoshida
Journal:  World J Urol       Date:  2009-11-11       Impact factor: 4.226

9.  Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity.

Authors:  F Aura Kullmann; Debra E Artim; Lori A Birder; William C de Groat
Journal:  J Neurosci       Date:  2008-02-20       Impact factor: 6.167

10.  Aging changes agonist induced contractile responses in permeabilized rat bladder.

Authors:  N Tugba Durlu-Kandilci; Merve Denizalti; Inci Sahin-Erdemli
Journal:  Age (Dordr)       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.